MedTrace Logo

W-PPMA for Postpartum Mothers

NCT05662605 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 281

Last updated 2024-04-18

No results posted yet for this study

Summary

To evaluate the feasibility and acceptability of W-PPMA among a diverse group of postpartum mothers.

Conditions

  • Postpartum Period

Interventions

DEVICE

W-PPMA

W-PPMA is a digital health tool designed specifically for the postpartum experience and is accessed through a mobile application which delivers evidence-based therapy through brief "conversations" with a fully automated relational agent called Woebot.

Sponsors & Collaborators

  • Scripps Translational Science Institute

    collaborator OTHER

  • Woebot Health

    lead INDUSTRY

Principal Investigators

  • Lase Ajayi, MD · Scripps Research Translational Institute

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-22
Primary Completion
2024-01-18
Completion
2024-03-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05662605 on ClinicalTrials.gov